Suppr超能文献

经皮胆囊取石术对高危患者是否安全有效?一项系统评价的证据

"Is percutaneous extraction of gallstones safe and effective in high-risk patients? Evidence from a systematic review".

作者信息

Latif Ejaz Ahmed, Mahdi Hijran, Zarour Ahmad, Aftab Zia, Aboumarzouk Omar M

机构信息

Department of Acute Care Surgery, Hamad Medical Corporation, Doha, Qatar.

Department of Surgery, Hamad Medical Corporation, Doha, Qatar; College of Medicine, Qatar University, Doha, Qatar; College of Medicine, University of Glasgow, Glasgow, UK.

出版信息

Surgeon. 2023 Apr;21(2):99-107. doi: 10.1016/j.surge.2022.04.007. Epub 2022 May 20.

Abstract

UNLABELLED

Gallstone disease in high-risk patients presents a management dilemma as cholecystectomy is often not performed due to their co-morbidities. Alternatively, such patients can be managed by percutaneous removal of gallstones. To date, there is paucity of high-quality evidence addressing the safety and efficacy of percutaneous cholecystolithotomy in high-risk patients. We aimed to conduct a systematic review on the feasibility of percutaneous gallstone removal in high-risk patients.

METHODS

A literature review was conducted using the Cochrane review and preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines without setting the time limits to assess the outcomes of percutaneous gallstone removal in high-risk patients.

RESULTS

Twelve studies were identified. A total of 435 patients underwent percutaneous gallstone removal. Success rate was 91%. Overall complications (including minor and major) were 28%. The mean length of stay was 7 days (range, 1-80). Procedure related mortality was 0.7%. The recurrence rate was 7%.

CONCLUSION

Percutaneous cholecystolithotomy is a safe and effective technique. Although, it cannot substitute the current standard treatment for gallstones i.e., laparoscopic cholecystectomy. However, it may be considered for the patients who cannot undergo laparoscopic cholecystectomy due to their comorbid conditions.

摘要

未标注

高危患者的胆结石疾病在治疗上存在两难困境,因为胆囊切除术常因患者合并症而无法实施。另外,此类患者可通过经皮取石进行治疗。迄今为止,关于经皮胆囊取石术在高危患者中的安全性和有效性,高质量证据匮乏。我们旨在对高危患者经皮取石的可行性进行系统评价。

方法

按照Cochrane系统评价和系统评价与Meta分析优先报告条目(PRISMA)指南进行文献综述,不设时间限制,以评估高危患者经皮取石的结果。

结果

共纳入12项研究。总计435例患者接受了经皮取石治疗。成功率为91%。总体并发症(包括轻微和严重并发症)发生率为28%。平均住院时间为7天(范围1 - 80天)。手术相关死亡率为0.7%。复发率为7%。

结论

经皮胆囊取石术是一种安全有效的技术。虽然它不能替代目前胆结石的标准治疗方法,即腹腔镜胆囊切除术。然而,对于因合并症无法接受腹腔镜胆囊切除术的患者,可考虑采用该方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验